Rakesh Adhikari

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

Jeroen Pollet, Wen‐Hsiang Chen, Leroy Versteeg et al. · Human Vaccines & Immunotherapeutics · 2021 · 100 citations · Full text

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

Wen‐Hsiang Chen, Junfei Wei, Rakhi Kundu et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2021 · 71 citations · Full text

Vaccine Development, Genetic Modification, Immunology +6

Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1

Jungsoon Lee, Zhuyun Liu, Wen‐Hsiang Chen et al. · Applied Microbiology and Biotechnology · 2021 · 55 citations · Full text

Engineering, Immunology, Process Development +20

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

Wen‐Hsiang Chen, Jeroen Pollet, Ulrich Strych et al. · Protein Expression and Purification · 2021 · 55 citations · Full text

Microbial Pathogens, Immunology, Immunodominance +17

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

Jeroen Pollet, Ulrich Strych, Wen‐Hsiang Chen et al. · Vaccine · 2022 · 45 citations · Full text